XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 120,215 $ 49 $ 414,956 $ (294,790)
Beginning Balance, shares at Dec. 31, 2023   49,131,363    
Issuance of common stock upon exercise of stock options, shares   194,119    
Issuance of common stock upon exercise of stock options 233   233  
Issuance of common stock upon vesting of restricted stock units   $ 1 (1)  
Issuance of common stock upon vesting of restricted stock units, shares   840,376    
Withholding taxes on net share settlement of restricted stock units (20)   (20)  
Warrant issuance 609   609  
ESPP purchase 450   450  
ESPP purchase, Shares   232,290    
Stock-based compensation expense 13,131   13,131  
Net Income (Loss) (39,661)     (39,661)
Ending Balance at Sep. 30, 2024 94,957 $ 50 429,358 (334,451)
Ending Balance, shares at Sep. 30, 2024   50,398,148    
Beginning Balance at Jun. 30, 2024 101,638 $ 50 424,973 (323,385)
Beginning Balance, shares at Jun. 30, 2024   50,136,131    
Issuance of common stock upon exercise of stock options, shares   38,936    
Issuance of common stock upon exercise of stock options 77   77  
Issuance of common stock upon vesting of restricted stock units, shares   223,081    
Stock-based compensation expense 4,308   4,308  
Net Income (Loss) (11,066)     (11,066)
Ending Balance at Sep. 30, 2024 94,957 $ 50 429,358 (334,451)
Ending Balance, shares at Sep. 30, 2024   50,398,148    
Beginning Balance at Dec. 31, 2024 87,523 $ 51 433,769 (346,297)
Beginning Balance, shares at Dec. 31, 2024   50,937,999    
Issuance of common stock upon exercise of stock options, shares   173,199    
Issuance of common stock upon exercise of stock options 148   148  
Issuance of common stock upon vesting of restricted stock units   $ 1 (1)  
Issuance of common stock upon vesting of restricted stock units, shares   1,219,371    
Withholding taxes on net share settlement of restricted stock units (55)   (55)  
ESPP purchase 433   433  
ESPP purchase, Shares   143,658    
Stock-based compensation expense 10,505   10,505  
Net Income (Loss) (34,264)     (34,264)
Ending Balance at Sep. 30, 2025 64,290 $ 52 444,799 (380,561)
Ending Balance, shares at Sep. 30, 2025   52,474,227    
Beginning Balance at Jun. 30, 2025 70,012 $ 52 442,352 (372,392)
Beginning Balance, shares at Jun. 30, 2025   52,033,403    
Issuance of common stock upon exercise of stock options, shares   95,661    
Issuance of common stock upon exercise of stock options 27   27  
Issuance of common stock upon vesting of restricted stock units   $ 0 0  
Issuance of common stock upon vesting of restricted stock units, shares   345,163    
Withholding taxes on net share settlement of restricted stock units (1)   (1)  
Stock-based compensation expense 2,421   2,421  
Net Income (Loss) (8,169)     (8,169)
Ending Balance at Sep. 30, 2025 $ 64,290 $ 52 $ 444,799 $ (380,561)
Ending Balance, shares at Sep. 30, 2025   52,474,227